Trisodium Citrate Dihydrate (E331(iii)) CAS: 6132-04-3
Related Insights
War‑Risk Insurance for Chemical & Fertilizer Tankers Set to Surge Again
War‑risk insurance premiums for chemical and fertilizer tankers are poised to climb sharply, raising freight costs and forcing shippers to rethink logistics strategies. The new price surge reflects heightened conflict risks in key shipping lanes and a tightening supply of under‑insured vessels. Companies must now balance cost, safety and supply chain resilience in a volatile market.
Trump Cuts 20% Hormuz Toll, A Rare De‑Escalation Amid Global Turbulence
In a surprising shift, President Trump has announced the removal of a proposed 20% toll on ships transiting the Strait of Hormuz. The decision offers temporary relief to shipping companies but is set against a backdrop of heightened geopolitical tensions. Maritime analysts examine how this change could reshape freight costs and chemical logistics for the next quarter.
War-Risk Insurance Under Scrutiny: What Rising Gulf Premiums Mean for Chemical Trade
War-risk insurance premiums surged by around 50% during the earlier Gulf disruption, increasing logistics costs for chemical shipments. Procurement and compliance teams should understand how insurance pricing and regulatory oversight can influence sourcing decisions and freight budgets.
Cape of Good Hope Routing: July 10 Updated Cost Assessment
The latest Cape of Good Hope routing update released on Friday, July 10, reveals a nuanced shift in freight costs for Asia‑Europe chemical shipments. Bunker Adjustment Factors and the recent BAF reset have reshaped container shipping rates, impacting procurement decisions across the supply chain.
Singapore's PCS Force Majeure: Why the Chemical Producer Released All Customers and What Buyers Should Do Next
Singapore's PCS force majeure declaration reshaped supply planning for petrochemical buyers across Asia. As Middle East shipping conditions improve, procurement teams now face important decisions on contract renegotiation, delivery schedules and pricing.
Pharmaceutical Supply Chain: H1 2026 Closing Risk Assessment
The first half of 2026 exposed major vulnerabilities in pharmaceutical supply chains. API concentration, shipping disruptions, and logistics risks are reshaping procurement strategies for H2 2026 and beyond.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.